A number of elements can influence decision-making when developing a global footprint within the clinical research environment. These elements include: knowledge of the regulatory framework and timelines, suitability of the healthcare setting, compatibility of standard of care, interest within the physician community, internal resource availability to train sites and monitor high quality data, and the competitive landscape.
In this presentation, Dr. Stansfield will discuss these elements, with a primary focus on the ways that patient access can influence the successful outcome of clinical research for a new product. She will also highlight the pros and cons of different approaches.
The audio conference is presented by Susan Stansfield, PhD, Executive Vice President Product Registration Europe, Africa & Asia Pacific, of PRA International. For more details, please visit our site www.fxconferences.com
